Iodine Uptake After a Low Iodine Diet
NCT05599139 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2026-02-06
Summary
The goal of this clinical trial is to compare the difference in thyroid uptake of a low dose radioactive iodine (10 MBq 123-I or 37 MBq 123-I) in athyreotic patients with differentiated thyroid carcinoma before and after a low iodine diet (LID) of 7 days.
The main question it aims to answer is:
• What is the difference in iodine uptake before and after a LID of 7 days?
Uptake of a low dose of 123-iodine will be measured in participants before and after a low iodine diet of 7 days. Researchers will compare the uptake (%) before and after the LID.
Conditions
- Differentiated Thyroid Cancer
Interventions
- BEHAVIORAL
-
Low iodine diet
Before ablation and possible subsequent therapy with 131I, patients have to follow a low iodine diet (LID), reducing the iodine intake \< 50 mcg per day and thereby depleting the overall iodine store in the body.
Sponsors & Collaborators
-
University Medical Center Groningen
lead OTHER
Principal Investigators
-
Wouter Zandee, Dr. · University Medical Center Groningen
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-22
- Primary Completion
- 2026-03-30
- Completion
- 2026-08-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Redifferentiation Therapy Using Alpha Lipoic Acid in Thyroid Cancer
NCT01396733 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123
NCT02278198 ·Status: COMPLETED ·Phase: PHASE1
-
Iodine I 131 in Treating Patients With Thyroid Cancer
NCT00416949 ·Status: TERMINATED ·Phase: NA
-
A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection.
NCT03986437 ·Status: COMPLETED
-
Hyperthyroid Follow-Up Study
NCT02989103 ·Status: COMPLETED
-
Clinical Study of Biokinetic Model of Iodine-131 in Total(Near) Thyroidectomy Patients.
NCT03349294 ·Status: COMPLETED
-
Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism
NCT01039818 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH)
NCT00926978 ·Status: TERMINATED ·Phase: NA
-
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
NCT03624751 ·Status: ACTIVE_NOT_RECRUITING
-
The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
NCT01707056 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
NCT05733013 ·Status: RECRUITING
-
the Microbiota Are Associated With Iodine-131 Therapy and Hypothyroidism
NCT03574051 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Antithyroid Drugs During Radioiodine Therapy
NCT00150137 ·Status: COMPLETED ·Phase: PHASE4
-
Iodine-129 Tracer Method for Investigating Human Iodine Metabolism
NCT02955745 ·Status: COMPLETED
-
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
NCT06853925 ·Status: RECRUITING ·Phase: NA
-
Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
NCT02393690 ·Status: COMPLETED ·Phase: PHASE2
-
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
NCT03647358 ·Status: RECRUITING ·Phase: PHASE1
-
Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases
NCT00749697 ·Status: UNKNOWN ·Phase: NA
-
CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer
NCT04495985 ·Status: ACTIVE_NOT_RECRUITING
-
Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma
NCT00673010 ·Status: COMPLETED ·Phase: PHASE1
-
OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation
NCT00439127 ·Status: COMPLETED
-
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
NCT03841617 ·Status: RECRUITING ·Phase: PHASE2
-
Block-replacement Therapy During Radioiodine Therapy
NCT00150124 ·Status: COMPLETED ·Phase: PHASE4
-
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
NCT00970359 ·Status: COMPLETED ·Phase: NA
-
Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine
NCT02773667 ·Status: COMPLETED